Literature DB >> 22773818

Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice.

Sheng Xiao1, Craig R Brooks, Chen Zhu, Chuan Wu, Johanna M Sweere, Sonia Petecka, Ada Yeste, Francisco J Quintana, Takaharu Ichimura, Raymond A Sobel, Joseph V Bonventre, Vijay K Kuchroo.   

Abstract

Tim-1, a type I transmembrane glycoprotein, consists of an IgV domain and a mucin domain. The IgV domain is essential for binding Tim-1 to its ligands, but little is known about the role of the mucin domain, even though genetic association of TIM-1 with atopy/asthma has been linked to the length of mucin domain. We generated a Tim-1-mutant mouse (Tim-1(Δmucin)) in which the mucin domain was deleted genetically. The mutant mice showed a profound defect in IL-10 production from regulatory B cells (Bregs). Associated with the loss of IL-10 production in B cells, older Tim-1(Δmucin) mice developed spontaneous autoimmunity associated with hyperactive T cells, with increased production of IFN-γ and elevated serum levels of Ig and autoantibodies. However, Tim-1(Δmucin) mice did not develop frank systemic autoimmune disease unless they were crossed onto the Fas-mutant lpr mice on a C57BL/6 background. Tim-1(Δmucin)lpr mice developed accelerated and fulminant systemic autoimmunity with accumulation of abnormal double-negative T cells and autoantibodies to a number of lupus-associated autoantigens. Thus, Tim-1 plays a critical role in maintaining suppressive Breg function, and our data also demonstrate an unexpected role of the Tim-1 mucin domain in regulating Breg function and maintaining self-tolerance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773818      PMCID: PMC3409739          DOI: 10.1073/pnas.1120914109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity.

Authors:  Gordon J Freeman; Jose M Casasnovas; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

Review 3.  TIM family of genes in immunity and tolerance.

Authors:  Vijay K Kuchroo; Jennifer Hartt Meyers; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

4.  Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.

Authors:  Rei Watanabe; Nobuko Ishiura; Hiroko Nakashima; Yoshihiro Kuwano; Hitoshi Okochi; Kunihiko Tamaki; Shinichi Sato; Thomas F Tedder; Manabu Fujimoto
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

5.  Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice.

Authors:  Vasileios C Kyttaris; Zheng Zhang; Vijay K Kuchroo; Mohamed Oukka; George C Tsokos
Journal:  J Immunol       Date:  2010-03-22       Impact factor: 5.422

6.  Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.

Authors:  José C Crispín; Mohamed Oukka; George Bayliss; Robert A Cohen; Christine A Van Beek; Isaac E Stillman; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury.

Authors:  Yoshinori Yamanishi; Jiro Kitaura; Kumi Izawa; Ayako Kaitani; Yukiko Komeno; Masaki Nakamura; Satoshi Yamazaki; Yutaka Enomoto; Toshihiko Oki; Hisaya Akiba; Takaya Abe; Tadasuke Komori; Yoshihiro Morikawa; Hiroshi Kiyonari; Toshiyuki Takai; Ko Okumura; Toshio Kitamura
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

8.  The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.

Authors:  Koichi Yanaba; Jean-David Bouaziz; Takashi Matsushita; Takeshi Tsubata; Thomas F Tedder
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

9.  Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.

Authors:  Henry Yim Wu; Francisco J Quintana; Howard L Weiner
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 10.  Regulatory B cells as inhibitors of immune responses and inflammation.

Authors:  Jean-David Bouaziz; Koichi Yanaba; Thomas F Tedder
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

View more
  69 in total

Review 1.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

2.  TIM-1 signaling is required for maintenance and induction of regulatory B cells.

Authors:  M Y Yeung; Q Ding; C R Brooks; S Xiao; C J Workman; D A A Vignali; T Ueno; R F Padera; V K Kuchroo; N Najafian; D M Rothstein
Journal:  Am J Transplant       Date:  2015-02-02       Impact factor: 8.086

3.  Checkpoint Receptor TIGIT Expressed on Tim-1+ B Cells Regulates Tissue Inflammation.

Authors:  Sheng Xiao; Lloyd Bod; Nathalie Pochet; Savithri Balasubramanian Kota; Dan Hu; Asaf Madi; Jessica Kilpatrick; Jingwen Shi; Allen Ho; Huiyuan Zhang; Raymond Sobel; Howard L Weiner; Terry B Strom; Francisco J Quintana; Nicole Joller; Vijay K Kuchroo
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

4.  T-cell immunoglobulin and mucin domain 1 deficiency eliminates airway hyperreactivity triggered by the recognition of airway cell death.

Authors:  Hye Young Kim; Ya-Jen Chang; Ya-Ting Chuang; Hyun-Hee Lee; David I Kasahara; Thomas Martin; Joyce T Hsu; Paul B Savage; Stephanie A Shore; Gordon J Freeman; Rosemarie H Dekruyff; Dale T Umetsu
Journal:  J Allergy Clin Immunol       Date:  2013-05-11       Impact factor: 10.793

5.  Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.

Authors:  Sheng Xiao; Craig R Brooks; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

6.  CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.

Authors:  Yong Zhang; Xiuying Zhang; Yan Xia; Xiao Jia; Hao Li; Yanyan Zhang; Zhen Shao; Ning Xin; Mingfeng Guo; Jing Chen; ShuangShuang Zheng; YuZhong Wang; Linlin Fu; Chenghua Xiao; Deqin Geng; Yonghai Liu; Guiyun Cui; Ruiguo Dong; Xiaoyu Huang; Tingyan Yu
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

7.  KIM-1-mediated phagocytosis reduces acute injury to the kidney.

Authors:  Li Yang; Craig R Brooks; Sheng Xiao; Venkata Sabbisetti; Melissa Y Yeung; Li-Li Hsiao; Takaharu Ichimura; Vijay Kuchroo; Joseph V Bonventre
Journal:  J Clin Invest       Date:  2015-03-09       Impact factor: 14.808

8.  CD27+TIM-1+ memory B cells promoted the development of Foxp3+ Tregs and were associated with better survival in acute respiratory distress syndrome.

Authors:  Guangfa Zhu; Yan Liu; Wenmei Zhang; Yan Huang; Keng Li
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

9.  Insulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells.

Authors:  Xiao-Rui Geng; Gui Yang; Meng Li; Jiang-Ping Song; Zhi-Qiang Liu; Shuqi Qiu; Zhigang Liu; Ping-Chang Yang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

10.  KIM-1-/TIM-1-mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation.

Authors:  Craig R Brooks; Melissa Y Yeung; Yang S Brooks; Hui Chen; Takaharu Ichimura; Joel M Henderson; Joseph V Bonventre
Journal:  EMBO J       Date:  2015-08-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.